CGON
Price
$25.55
Change
-$0.73 (-2.78%)
Updated
Jun 20 closing price
Capitalization
1.95B
47 days until earnings call
GNLX
Price
$2.97
Change
+$0.05 (+1.71%)
Updated
Jun 20 closing price
Capitalization
112.07M
59 days until earnings call
Interact to see
Advertisement

CGON vs GNLX

Header iconCGON vs GNLX Comparison
Open Charts CGON vs GNLXBanner chart's image
CG Oncology
Price$25.55
Change-$0.73 (-2.78%)
Volume$987.48K
Capitalization1.95B
Genelux
Price$2.97
Change+$0.05 (+1.71%)
Volume$277.49K
Capitalization112.07M
CGON vs GNLX Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. GNLX commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and GNLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (CGON: $25.55 vs. GNLX: $2.97)
Brand notoriety: CGON and GNLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 71% vs. GNLX: 182%
Market capitalization -- CGON: $1.95B vs. GNLX: $112.07M
CGON [@Biotechnology] is valued at $1.95B. GNLX’s [@Biotechnology] market capitalization is $112.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileGNLX’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • GNLX’s FA Score: 0 green, 5 red.
According to our system of comparison, GNLX is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 2 TA indicator(s) are bullish while GNLX’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 2 bullish, 3 bearish.
  • GNLX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GNLX is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -1.20% price change this week, while GNLX (@Biotechnology) price change was -2.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.70%. For the same industry, the average monthly price growth was +28.03%, and the average quarterly price growth was +14.56%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

GNLX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+9.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.95B) has a higher market cap than GNLX($112M). GNLX YTD gains are higher at: 25.847 vs. CGON (-10.914). GNLX has higher annual earnings (EBITDA): -28.78M vs. CGON (-134.35M). CGON has more cash in the bank: 688M vs. GNLX (35.1M). CGON has less debt than GNLX: CGON (1.04M) vs GNLX (1.79M). CGON has higher revenues than GNLX: CGON (662K) vs GNLX (0).
CGONGNLXCGON / GNLX
Capitalization1.95B112M1,739%
EBITDA-134.35M-28.78M467%
Gain YTD-10.91425.847-42%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M35.1M1,960%
Total Debt1.04M1.79M58%
TECHNICAL ANALYSIS
Technical Analysis
CGONGNLX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 6 days ago
89%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFWJX17.46N/A
N/A
MFS Global Total Return R4
JFNCX54.61N/A
N/A
Janus Henderson Global Life Sciences C
APWEX16.71N/A
N/A
Cavanal Hill World Energy Investor
NUEIX21.22N/A
N/A
Northern US Quality ESG I
PVETX16.87N/A
N/A
PACE Small/Medium Co Val Eq P2

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-2.78%
IDYA - CGON
60%
Loosely correlated
-0.87%
ACLX - CGON
56%
Loosely correlated
-1.28%
SYRE - CGON
56%
Loosely correlated
-0.60%
NUVL - CGON
55%
Loosely correlated
-0.70%
KYMR - CGON
54%
Loosely correlated
-1.23%
More

GNLX and

Correlation & Price change

A.I.dvisor tells us that GNLX and SNSE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNLX and SNSE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
+1.71%
SNSE - GNLX
32%
Poorly correlated
-0.13%
CRSP - GNLX
31%
Poorly correlated
-0.38%
CGON - GNLX
30%
Poorly correlated
-2.78%
BEAM - GNLX
30%
Poorly correlated
-1.29%
BHVN - GNLX
29%
Poorly correlated
+0.49%
More